DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Eli Lilly - 5 Cramer - 3 Viking - 3 — - 3 CNBC's Jim Cramer - 2 he's - 2 it's - 2 Brian Lian - 2
Top related locs:
U.S Lilly Ole Andreas Halvorsen's Viking Iceland Egypt Stamford Swiss New York City
Top related orgs:
Viking - 8 Novo Nordisk - 5 Viking Therapeutics - 4 Novo - 3 CNBC - 3 Service - 2 Nvidia - 2 Devices - 2

Search resuls for: "Viking's"


15 mentions found


☆ Cramer says he's willing to pay up for Viking, the biggest IPO of the year
  + stars: | 2024-05-02 | by ( Julie Coleman | ) www.cnbc.com   time to read: +1 min
CNBC's Jim Cramer on Thursday reviewed the IPO of Viking , a cruise line whose market debut this week was the biggest of the year so far. And despite its hefty price tag, Cramer said he's willing to pay up for the stock. Viking stands apart from much of the competition — its ships don't have casinos, children aren't allowed, and it specifically targets a wealthy consumer. He conceded that Viking doesn't have a perfect balance sheet, but neither do the other publicly-traded cruise lines. But to Cramer, Viking deserves a premium.
Persons: CNBC's Jim Cramer, Cramer, he's, aren't, it's, Cramer , Viking, Viking's, Viking Organizations: Viking Locations: Iceland, Egypt
☆ Why a Viking Global portfolio manager is worried about a multi-strat meltdown, plus his favorite European luxury stock
  + stars: | 2024-04-19 | by ( Bradley Saacks | ) www.businessinsider.com   time to read: +3 min
download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewCompared to some of its Tiger Cub peers, $48 billion Viking Global's highs and lows have been more muted. This story is available exclusively to Business Insider subscribers. "If the stock went up 25% tomorrow, we would probably sell it absent any other fundamental change in the business." AdvertisementThe firm's flagship long-short fund was up 5.8% in the first quarter, a person close to the firm told Business Insider, and its long-only fund returned 10.1%.
Persons: —, Justin Walsh, Walsh, Hermes Organizations: Service, Tiger Cub, Tiger, Business, Harvard Business School Investment, Citadel, Business Insider, Cartier Locations: Stamford, Swiss
☆ Viking Therapeutics stock jumps more than 25% on promising weight loss pill data
  + stars: | 2024-03-26 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +2 min
Viking Therapeutics shares jumped more than 25% on Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year. The study results add to the excitement around the drugmaker's prospects in the budding weight loss drug market. Based on Tuesday's results, Viking plans to start a phase two trial of its weight loss pill later this year. Weight loss for those patients ranged up to 3.6% higher than those who received a placebo. Viking CEO Brian Lian said during a conference call on Tuesday that it's unclear "how durable" the weight loss is.
Persons: Eli Lilly, Viking, Brian Lian Organizations: Viking Therapeutics, Novo Nordisk, Viking
☆ Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
  + stars: | 2024-03-03 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +8 min
In this article VKTX Follow your favorite stocks CREATE FREE ACCOUNTCr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. Their treatments sparked the weight loss drug industry gold rush over the past year despite their hefty price tags and barriers to insurance coverage. It's too early to say whether Viking's drug could have an edge over existing or developing weight loss treatments. The pharmaceutical giant could also launch a slate of other weight loss treatments over the next few years that may have advantages over Zepbound, whether they offer more weight loss or convenience. That could give Viking the commercial and manufacturing capabilities needed to compete in the weight loss drug market.
Persons: Eli Lilly, Eli Lilly's Zepbound, Viking, Goldman Sachs, Eli Lilly’s, Brendan Mcdermid, GLP, Brian Lian, William Blair, Andy Hsieh, Hsieh, Eli Lilly's, Jefferies, Akash Tewari, doesn't, Mike Segar, Lian, William Blair's Hsieh, Oppenheimer, Jay Olson Organizations: Getty Images Biotech, Viking Therapeutics, Novo Nordisk, Reuters, Viking, Novo, U.S . Food, Drug Administration, Company, Deutsche Bank, CNBC Locations: New York City, Branchburg , New Jersey
☆ Costco Next is the chain's best-kept secret that's free for members. I've already saved thousands of dollars using it.
  + stars: | 2024-03-01 | by ( Louisa Eunice | ) www.businessinsider.com   time to read: +2 min
I love my Costco membership, especially because I get access to the Costco Next program. Costco Next offers members limited-time deals from name brands, like Viking and Travelpro. I saved thousands buying a shed through Costco Next, and I regularly see 40% discounts on products. I've also seen offers available for discounted caskets, playhouses, bicycles, phone cases, slippers, and baby toys. Viking; Costco NextCostco Next offers vary, but I've seen many products for 30% to 50% off their original price.
Persons: —, It's, I've, Dearforms Organizations: Costco, Costco Next, Service
☆ Here is Eli Lilly's competitive edge in GLP-1 obesity drugs and Abbott's secondary play
  + stars: | 2024-02-29 | by ( Jeff Marks | ) www.cnbc.com   time to read: +4 min
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.
Persons: Jim Cramer, Dow, Jim, Chris Danely, Cramer, Eaton, Eli Lilly, Lilly, Jim Cramer's Organizations: CNBC, Dow, Nasdaq, Semiconductor, Citi, Broadcom, Nvidia, Devices, Micron, Dell Technologies, Autodesk, Novo Nordisk, Abbott Laboratories, Novo, Viking, Jim Cramer's Charitable
☆ Viking's obesity drug study results are 'almost flawless', says Oppenheimer's Jay Olson
  + stars: | 2024-02-27 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailViking's obesity drug study results are 'almost flawless', says Oppenheimer's Jay OlsonJay Olson, Oppenheimer biotech analyst, joins 'Fast Money' to talk Viking's best trading day ever and the results of its obesity drug study.
Persons: Oppenheimer's Jay Olson Jay Olson, Oppenheimer
☆ Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
  + stars: | 2024-02-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com   time to read: +8 min
VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.
Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly
☆ Jim Cramer: Viking Therapeutics' weight-loss data not enough to dethrone Eli Lilly in GLP-1s
  + stars: | 2024-02-27 | by ( Kevin Stankiewicz | ) www.cnbc.com   time to read: +2 min
CNBC's Jim Cramer on Tuesday downplayed the competitive risk to Eli Lilly — a longtime holding in his Charitable Trust — presented by Viking Therapeutics ' new weight-loss drug data. Currently, Eli Lilly and Wegovy maker Novo Nordisk are the dominant players in the GLP-1 category. Eli Lilly and Novo Nordisk are far larger, worth around $733 billion and $550 billion as of Tuesday. Eli Lilly shares, among the best performers in the S & P 500 this year, fell slightly Tuesday. Cramer's Charitable Trust, the portfolio used by the CNBC Investing Club , has long owned Eli Lilly.
Persons: CNBC's Jim Cramer, Eli Lilly —, —, Eli Lilly, Cramer, Eli Lilly's tirzepatide, David Ricks, Lilly's, retatrutide Organizations: Viking Therapeutics, Novo Nordisk, Viking, Leerink Partners, Charitable Trust, CNBC Locations: Lilly
☆ Ole Andreas Halvorsen's Viking Global bought this regional bank in the fourth quarter
  + stars: | 2024-02-15 | by ( Alex Harring | ) www.cnbc.com   time to read: +2 min
Despite broad concerns surrounding the health of regional banks, Ole Andreas Halvorsen's Viking Global bought into one key name in the sector in the fourth quarter. The move came near the end of a turbulent year for regional banks after the shuttering of Silicon Valley Bank , First Republic Bank and Signature Bank led investors to question the regionals' business model. Shares of U.S. Bancorp climbed more than 30% in the fourth quarter, but the stovck still ended the year down about 1%. The sector took a hit this year following New York Bancorp 's dismal fourth quarter earnings , which showed a loss, a large reserve against weaker future credits and slashed the dividend. Halvorsen went even further and zeroed out stakes in Microsoft and Arm Holdings , the British chip and software designer that went public last September.
Persons: Ole Andreas Halvorsen's, Halvorsen, Julian Robertson, InsiderScore, Lamb Weston Organizations: Ole Andreas Halvorsen's Viking Global, Viking Global, . Bancorp, Silicon Valley Bank, First Republic Bank, Signature Bank, U.S . Bancorp, Regional Banking, New York Bancorp, Viking, Tiger Management, Devices, Microsoft, Arm Holdings, Mastercard, Electric, Colgate, Palmolive Locations: Ole Andreas Halvorsen's Viking, Minneapolis, Silicon, U.S, Deere
☆ Cramer's Lightning Round: 'I'm moving on' from Herbalife
  + stars: | 2023-10-10 | by ( Julie Coleman | ) www.cnbc.com   time to read: +1 min
Stock Chart Icon Stock chart icon Spirit AeroSystems' year-to-date stock performance. Stock Chart Icon Stock chart icon CVS's year-to-date stock performance. Stock Chart Icon Stock chart icon Abbott's year-to-date stock performance. Stock Chart Icon Stock chart icon Viking's year-to-date stock performance. Stock Chart Icon Stock chart icon Herbalife's year-to-date stock performance.
Persons: AeroSystems, Abbott, Elon Musk, I'm, I've, Jim Cramer's Organizations: Honeywell, CVS, Elon
☆ Viking Global slashes Amazon and insurance positions, adds to bets in biotech
  + stars: | 2023-08-15 | by ( Brian Evans | ) www.cnbc.com   time to read: +2 min
Ole Andreas Halvorsen's Viking Global hedge fund slashed its holding in Amazon in the second quarter and stepped up bets in biotech, according to the latest 13F filing with the U.S. Securities and Exchange Commission . The so-called Tiger Cub's entirely new positions included a $78 million stake in Alibaba , $6.5 million in C3.ai and $132 million worth of chipmaker Nvidia . Viking Global also cut investments in the CSX railroad nearly 42%. Elsewhere, Viking Global purchased $278 million worth of Netflix stock in the second quarter and opened a $159 million position in shipping giant UPS . Viking Global managed about $24 billion in 13F securities at the end of the second quarter, according to WhaleWisdom.com .
Persons: Ole Andreas Halvorsen's, Halvorsen, Julian Robertson, Jack Dorsey's Block, Phillip Morris, Philip Morris Organizations: Ole Andreas Halvorsen's Viking Global, U.S . Securities, Exchange Commission, Viking Global, Tiger Management, Nvidia, Viking, CSX, TJX, Meta, Netflix, UPS, Chubb Limited, Tenet Healthcare, General Electric, UnitedHealth Group, Constellation Energy, GE Locations: Ole Andreas Halvorsen's Viking, Alibaba, Viking, Progressive
☆ Viking joins obesity drug race after promising early trial data
  + stars: | 2023-03-28 | by ( Mariam Esunny | ) www.reuters.com   time to read: +2 min
March 28 (Reuters) - Viking Therapeutics Inc's (VKTX.O) experimental obesity drug helped reduce weight and was safe in an early-stage study, the company said on Tuesday, sparking a 60% rise in its shares. While Novo Nordisk (NOVOb.CO) already has its obesity drug, Wegovy, in the market, Eli Lilly is expecting approval for its treatment later this year. That could also make Viking a potential acquisition target, Laidlaw & Company analyst Yale Jen said. Viking said it was planning to test higher doses of the drug over a longer treatment window in a mid-stage trial, versus a shorter limit in the current, early-stage trial. Shares of Viking were trading at $14.15, bringing the drugmaker closer to a market capitalization of $1 billion.
☆ Viking cruise passengers tried to maintain their sense of humor after marine growth on the ship's hull left them trapped onboard for 10 days: 'It was a plot twist'
  + stars: | 2023-01-12 | by ( Erin Snodgrass | ) www.businessinsider.com   time to read: +7 min
Passengers aboard the Viking Orion missed several port stops due to marine growth on the ship. It was to be the "trip of a lifetime," Heydrick told Insider. The Viking Orion made headlines last month after the cruise ship missed several planned port stops due to "marine growth" found in the ship's hull. Cruise liner Viking Orion (L) is moored in Melbourne's Port Philip Bay on March 24, 2020. "Viking Orion" cruise ship under the flag of Norway is seen anchored at Bodrum Cruise Port in Bodrum district of Mugla, Turkey on April 18, 2021.
☆ Passengers to be compensated after algae spoils Australia-New Zealand cruise
  + stars: | 2023-01-04 | by ( Joseph Campbell Lewis Jackson | Joseph Campbell | Lewis Jackson | ) www.reuters.com   time to read: +2 min
The 930-guest capacity Viking Orion docked in Sydney on Wednesday, the final stop on what is normally a 15-day, 9-stop cruise of New Zealand and Australia. But plans went awry, local media reported, after New Zealand officials asked the ship to leave the country's waters part way through its cruise after finding small amounts of biofoul - plants, algae and small animals - that grow on ship hulls. Tickets for a 15-day Auckland to Sydney cruise departing Jan 10 range from A$8,995 ($6,066.23) to A$29,995 on the Viking website. Viking's Orion is the second cruise ship to fall afoul of New Zealand officials in the past month. New Zealand fisheries officials stopped cruise ship Coral Princess entering the country's waters in December after finding snails on the hull.
0 next >>
Total: 15